Results 131 to 140 of about 526 (152)

Solriamfetol improves driving performance in patients with excessive sleepiness

The Brown University Psychopharmacology Update, 2022
Adults with excessive daytime sleepiness associated with obstructive sleep apnea (OSA) who received solriamfetol showed improved driving performance relative to placebo in a two‐period crossover study. Solriamfetol resulted in reduced standard deviation of lateral position (SDLP) at 2 and 6 hours post‐dose.
openaire   +1 more source

Solriamfetol titration and administration (start): Characteristics of patients with narcolepsy and solriamfetol prescriber rationale

Journal of the Neurological Sciences, 2021
Michael Thorpy, Danielle Hyman, Gregory Parks, Abby Chen, Catherine Foley, Diane Ito, Haramandeep Singh   +6 more
openaire   +1 more source

Solriamfetol for Excessive Sleepiness in Early-Morning Shift Work Disorder

NEJM Evidence
More individuals work early-morning shifts than night shifts, yet investigations into the treatment of shift work disorder (SWD) in this population are lacking.This randomized, double-blind, placebo-controlled trial evaluated the efficacy of solriamfetol, a selective dopamine and norepinephrine reuptake inhibitor, for treating excessive sleepiness in ...
Kirsi-Marja, Zitting, Katherine R, Gilmore, Brandon J, Lockyer, Eileen B, Leary, Wei, Wang, Nicolas C, Issa, Stuart F, Quan, Jonathan S, Williams, Jeanne F, Duffy, Charles A, Czeisler   +9 more
openaire   +2 more sources

Einstufung von Solriamfetol geändert

NeuroTransmitter, 2021
openaire   +1 more source

Solriamfetol Titration and AdministRaTion (START) in Patients with Obstructive Sleep Apnea: A Retrospective Chart Review and Hypothetical Patient Scenario

Advances in Therapy, 2022
Haramandeep Singh, Danielle Hyman, Gregory S Parks   +2 more
exaly  

Efficacy and safety of solriamfetol for excessive sleepiness in narcolepsy and obstructive sleep apnea: findings from randomized controlled trials

Sleep Medicine, 2021
Jiahe Wang, Heng Gao
exaly  

Comparison of Solriamfetol and Modafinil on Arousal and Anxiety-Related Behaviors in Narcoleptic Mice

Neurotherapeutics, 2022
Noriaki Sakai, Seiji Nishino, Sakai Noriaki   +2 more
exaly  

Summary of opinion: Sunosi,solriamfetol

Case Medical Research, 2019
openaire   +2 more sources

Effects of Solriamfetol on Driving Performance in Participants With Narcolepsy (2274)

Neurology, 2021
Frederick Vinckenbosch, Gert Jan Lammers, Sebastiaan Overeem, Dan Chen, Grace Wang, Lawrence Carter, Kefei Zhou, Johannes G. Ramaekers, Annemiek Vermeeren   +8 more
openaire   +1 more source

Solriamfetol real world experience study (SURWEY): Initiation, titration, safety, effectiveness, and experience during follow-up for patients with narcolepsy from Germany

Sleep Medicine, 2023
Yaroslav Winter, Geert Mayer, Sylvia Kotterba   +2 more
exaly